Labor shortening drug tested in new study

NCT ID NCT07184099

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study tested whether the drug phloroglucinol can shorten the active phase of labor in pregnant women. Researchers gave the drug intravenously to 134 women aged 18-35 with full-term pregnancies. The goal was to see if it reduced the time from labor diagnosis to full cervical dilation.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

phloroglucinol

What this could lead to

If it works, this could offer a simple way to shorten labor for some women, reducing discomfort and complications.

What could go wrong

This is a small, completed study with 134 participants. Results may not apply to all women, and the drug may not be effective or could cause side effects like allergic reactions.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LABOR are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Combined Military Hospital

    Attock, Punjab Province, 43100, Pakistan